Stocks and Investing Stocks and Investing
Tue, October 29, 2019
[ 12:00 AM ] - WOPRAI
Betsy Graseck Maintained (AXP) at Buy with Increased Target to $149 on, Oct 29th, 2019
[ 12:00 AM ] - WOPRAI
Savanthi Syth Maintained (AZUL) at Buy with Increased Target to $45 on, Oct 29th, 2019
[ 12:00 AM ] - WOPRAI
Richard Safran Maintained (BA) at Hold with Decreased Target to $365 on, Oct 29th, 2019
[ 12:00 AM ] - WOPRAI
Leo Mariani Initiated (APA) at Hold on, Oct 29th, 2019
[ 12:00 AM ] - WOPRAI
Randy Abrams Upgraded (AMKR) to Buy and Increased Target to $15 on, Oct 29th, 2019
[ 12:00 AM ] - WOPRAI
Robert Moskow Maintained (BYND) at Hold with Decreased Target to $115 on, Oct 29th, 2019
[ 12:00 AM ] - WOPRAI
John Baumgartner Maintained (BYND) at Hold with Decreased Target to $100 on, Oct 29th, 2019
[ 12:00 AM ] - WOPRAI
Brian Holland Maintained (BYND) at Sell with Decreased Target to $84 on, Oct 29th, 2019
[ 12:00 AM ] - WOPRAI
Keith Weiss Maintained (AKAM) at Buy with Increased Target to $103 on, Oct 29th, 2019
[ 12:00 AM ] - WOPRAI
Brad Zelnick Maintained (AKAM) at Hold with Increased Target to $85 on, Oct 29th, 2019
[ 12:00 AM ] - WOPRAI
Mark Kelleher Maintained (AKAM) at Strong Buy with Increased Target to $105 on, Oct 29th, 2019
[ 12:00 AM ] - WOPRAI
Jeff Van Rhee Maintained (AKAM) at Strong Buy with Increased Target to $110 on, Oct 29th, 2019
[ 12:00 AM ] - WOPRAI
Shebly Seyrafi Maintained (AKAM) at Buy with Increased Target to $95 on, Oct 29th, 2019
[ 12:00 AM ] - WOPRAI
Mark Mahaney Maintained (AKAM) at Hold with Increased Target to $91 on, Oct 29th, 2019
Mon, October 28, 2019
[ 12:00 AM ] - WOPRAI
Matthew DeYoe Downgraded (ALB) to Sell on, Oct 28th, 2019
[ 12:00 AM ] - WOPRAI
Jamie Baker Downgraded (ALK) to Hold and Decreased Target to $76 on, Oct 28th, 2019
[ 12:00 AM ] - WOPRAI
Dick Bove Upgraded (BAC) to Strong Buy on, Oct 28th, 2019
[ 12:00 AM ] - WOPRAI
Sheila Kahyaoglu Maintained (BA) at Strong Buy with Decreased Target to $420 on, Oct 28th, 2019
[ 12:00 AM ] - WOPRAI
Myles Walton Maintained (B) at Hold with Increased Target to $60 on, Oct 28th, 2019
[ 12:00 AM ] - WOPRAI
Daniel Mckenzie Upgraded (AZUL) to Strong Buy and Increased Target to $51 on, Oct 28th, 2019
[ 12:00 AM ] - WOPRAI
Glenn Chin Maintained (ALV) at Hold with Increased Target to $75 on, Oct 28th, 2019
[ 12:00 AM ] - WOPRAI
Jeff Kessler Maintained (ALLE) at Hold with Increased Target to $116 on, Oct 28th, 2019
[ 12:00 AM ] - WOPRAI
Brett Andress Maintained (BC) at Buy with Increased Target to $65 on, Oct 28th, 2019
[ 12:00 AM ] - WOPRAI
Garcha Kulbinder Maintained (AAPL) at Hold with Increased Target to $55 on, Oct 28th, 2019
[ 12:00 AM ] - WOPRAI
Wamsi Mohan Maintained (AAPL) at Strong Buy with Increased Target to $65 on, Oct 28th, 2019
[ 12:00 AM ] - WOPRAI
Kyle Mcnealy Maintained (AAPL) at Strong Buy with Increased Target to $71 on, Oct 28th, 2019
[ 12:00 AM ] - WOPRAI
Samik Chatterjee Maintained (AAPL) at Buy with Increased Target to $275 on, Oct 28th, 2019
[ 12:00 AM ] - WOPRAI
James Fotheringham Maintained (V) at Buy with Increased Target to $239 on, Oct 28th, 2019
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (ARGX) at Buy with Decreased Target to $170 on, Oct 28th, 2019
[ 12:00 AM ] - WOPRAI
Gregory Renza Initiated (APRE) at Buy and Held Target at $660 on, Oct 28th, 2019

Gregory Renza Initiated (APRE) at Buy and Held Target at $660 on, Oct 28th, 2019


Published on 2024-10-26 17:27:51 - WOPRAI, Gregory Renza
  Print publication without navigation


Gregory Renza of RBC Capital, Initiated "Aprea Therapeutics, Inc." (APRE) at Buy and Held Target at $660 on, Oct 28th, 2019.

Gregory, nor any peers, have made any analyst calls on APRE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources